Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Celcuity Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CELC
Nasdaq
8731
https://www.celcuity.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Celcuity Inc
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
- Apr 4th, 2024 11:05 am
Celcuity Gains 12%, Insider Trades Reap Benefit
- Apr 3rd, 2024 10:41 am
Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript
- Apr 1st, 2024 5:38 pm
Q4 2023 Celcuity Inc Earnings Call
- Mar 28th, 2024 10:51 am
Celcuity Inc (CELC) Reports Full Year 2023 Financial Results and Highlights Key Developments
- Mar 27th, 2024 9:51 pm
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- Mar 27th, 2024 8:01 pm
Why Celcuity (CELC) Might Surprise This Earnings Season
- Mar 21st, 2024 3:17 pm
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call
- Mar 20th, 2024 11:05 am
Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024
- Mar 6th, 2024 12:05 pm
Celcuity to Participate in Cowen’s 44th Annual Health Care Conference
- Feb 28th, 2024 12:05 pm
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer
- Feb 22nd, 2024 9:05 pm
Celcuity Appoints Eldon Mayer as Chief Commercial Officer
- Feb 20th, 2024 12:05 pm
Celcuity Inc. (NASDAQ:CELC) has caught the attention of institutional investors who hold a sizeable 33% stake
- Jan 22nd, 2024 12:30 pm
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium
- Dec 6th, 2023 1:30 pm
Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium
- Dec 1st, 2023 4:02 pm
Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference
- Nov 22nd, 2023 1:05 pm
Celcuity Inc. (NASDAQ:CELC) Q3 2023 Earnings Call Transcript
- Nov 14th, 2023 3:50 pm
Q3 2023 Celcuity Inc Earnings Call
- Nov 14th, 2023 2:41 am
Celcuity Inc (CELC) Reports Q3 2023 Financial Results and Strategic Developments
- Nov 13th, 2023 3:54 pm
Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
- Nov 13th, 2023 12:05 pm
Scroll